516

N-{(1S)-1-cyclohexyl-2-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl}-N~2~-methyl-L-alaninamide

Created:	2009-04-15
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 516 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	72
Chiral Atom Count	3
Bond Count	76
Aromatic Bond Count	17

2D diagram of 516

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{(1S)-1-cyclohexyl-2-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-2-oxoethyl}-N~2~-methyl-L-alaninamide
Systematic Name (OpenEye OEToolkits)	(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-(4-naphthalen-1-yl-1,3-thiazol-2-yl)pyrrolidin-1-yl]-2-oxo-ethyl]-2-methylamino-propanamide
Formula	C₂₉ H₃₆ N₄ O₂ S
Molecular Weight	504.687
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NC(C(=O)N1CCCC1c2nc(cs2)c4c3ccccc3ccc4)C5CCCCC5)C(NC)C
SMILES	CACTVS	3.341	CN[CH](C)C(=O)N[CH](C1CCCCC1)C(=O)N2CCC[CH]2c3scc(n3)c4cccc5ccccc45
SMILES	OpenEye OEToolkits	1.5.0	CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2c3nc(cs3)c4cccc5c4cccc5)NC
Canonical SMILES	CACTVS	3.341	CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3scc(n3)c4cccc5ccccc45
Canonical SMILES	OpenEye OEToolkits	1.5.0	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)c4cccc5c4cccc5)NC
InChI	InChI	1.03	InChI=1S/C29H36N4O2S/c1-19(30-2)27(34)32-26(21-11-4-3-5-12-21)29(35)33-17-9-16-25(33)28-31-24(18-36-28)23-15-8-13-20-10-6-7-14-22(20)23/h6-8,10,13-15,18-19,21,25-26,30H,3-5,9,11-12,16-17H2,1-2H3,(H,32,34)/t19-,25-,26-/m0/s1
InChIKey	InChI	1.03	OWHXKYSKEROHGU-CNVLFFCLSA-N

Related Resource References

Resource Name	Reference
PubChem	44820626
ChEMBL	CHEMBL1091044

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.